Scientists in Singapore have assembled the world’s largest and highest-resolution atlas of gastric cancer, a leadi...
AMD and Nanyang Technological University, Singapore (NTU Singapore), with the support of the Singapore Economic Developm...
Aevice Health, Singapore-based MedTech company dedicated to improving the lives of 545 million people with chronic respi...
A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has created a laser-powered devi...
Singapore Medical Group (SMG), a regional multi-disciplinary specialist healthcare services provider and Aurum Land, a s...
US-based 10x Genomics has marked a major Asia Pacific (APAC) expansion with the grand opening celebration of i...
The Health Sciences Authority (HSA) in Singapore has granted an interim authorisation under the Pandemic Special Access ...
A research team led by Professor Lim Chwee Teck from the National University of Singapore’s (NUS) Department ...
The Housing & Development Board (HDB), the National University Health System (NUHS) and the National University of S...
More than 50 percent of the world’s hip fractures are expected to occur in the Asia Pacific by the year 2050. In a...
With the advent of induced pluripotent stem cell (iPSC) and embryonic stem cell (ESC) technology, regenerative stem cell...
Medtronic plc has announced the launch of the Medtronic Open Innovation Platform (OIP) in Singapore. The OIP will b...
A team of experts led by the National Environment Agency in Singapore has suggested that dengue could be suppressed...
Scientists from Duke-NUS Medical School have partnered with Singapore biotechnology company Xylonix ...
Singapore's CellResearch Corporation (CRC) has received an ‘Innovation Passport’ for its stem cell therapy C...
Singapore's Ngee Ann Polytechnic launches Ngee Ann Polytechnic’s (NP) Robotics Research & Innovation Centre (R...
Singapore's AUM Biosciences (AUM) has completed of $27 million series A funding round to develop a drug pipeline focused...
HER2+ metastatic breast cancer (HER2+ mBC) is an aggressive type of breast cancer with poor prognosis. Whilst various ta...
